|
Defining Appropriate Outcome Measures for Older Persons with Multiple Chronic Conditions
|
Meeting/ Workshop
|
AHRQ
|
NIA
|
Inter-Agency Agreement between Agency for Healthcare Research & Quality and National Institute on Aging, NIH. The purpose of this Inter-Agency Agreement (IAA) is to authorize the transfer of funds appropriated for the Agency for Healthcare Research and Quality (AHRQ) to the National Institute on Aging (NIA/NIH), in order to support an expert panel meeting, as well as products and activities resulting from this event, that will assess the current state of available metrics for individuals with multiple chronic conditions, prioritize usable measures based upon stakeholder needs, and foster the development or refinement of additional promising outcome measures. The findings from this event should have broad applicability and uptake in research, clinical care, and program evaluation efforts to improve the health of the population burdened by multiple chronic conditions.
|
|
Demand Reduction Interagency Working Groups
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
OD/OSP, NIAAA, NIDA
|
To encourage greater cross-talk and Agency participation in developing the National Drug Control Strategy, White House Office of National Drug Control Policy (ONDCP) reconstituted its demand reduction workgroups focusing on prevention, emerging threats, healthcare delivery, justice systems, military veterans and their families, and performance and accountability measures. These working groups aim to prevent substance abuse and related negative consequences by implementing a prevention framework to serve as a foundation for collaboration among Federal agencies in the development of joint initiatives that serve States and communities across the Nation.
|
|
Detail with Environmental Health Team at the Office of the Assistant Secretary for Health
|
Other
|
OS
|
NICHD
|
This detail with with an Public Program Analyst in the Science Policy, Planning and Evaluation Branch/NICHD detailing with the Environmental Health Team at the Office of the Assistant Secretary for Health. This collaboration involved seeking to improve health among minority, low-income, and Tribal Indian populations and promoting a "Health In All Policies" (children, pregnant women, families, individuals living with disabilities, LGBTI). The Public Program Analyst reviewed America''s Children and the Environment (clearance), drafted abstracts about the Environmental Justice Strategy for health disparities meetings, coordinated crosscutting groups, helped plan/prepare Environmental Justice Stakeholders Implementation meeting, and the Environmental Strategy strategic planning alignment.
|
|
Detection of Cognitive Impairment: The Search for an Evidence-Based Screening Tool
|
Other
|
AHRQ, CDC, CMS
|
NIA, NIMH, NINDS, NINR
|
In January 2011, a New Requirement in the Medicare Annual Wellness Visit is for an Evidence-Based Screening Tool for the Detection of Cognitive Impairment. This new requirement was included in Public Law 111 - 148, the Patient Protection and Affordable Care Act as an additional element under Sec. 4103: Medicare Coverage of Annual Wellness Visit Providing a Personalized Prevention Plan. The Centers for Medicaid and Medicare Services (CMS) noted that in their solicitation for public comments before implementing the new regulation, the definition of cognitive impairment in the statute “was vague and commenters suggested adding a standardized screening tool.” The law only stipulates that providers assess an individual’s cognitive function by “direct observation, with due consideration of information obtained by way of patient report, concerns raised by family members, friends, caretakers, or others.” Most providers routinely use these methods during outpatient visits to assess general well-being and function, but are not always effective in specifically detecting cognitive impairment. Other concerns with this subjective method include false positive findings and questionable, expensive neurological workups. CMS and others, therefore, have identified the need for some standardized instrument or set of tools that could be used by providers. Since the annual wellness visit is scheduled for 45 minutes and has other required elements, the tool would need to be short, with no associated cost, easy to administer, sensitive to change over time, and normed for use in the Medicare beneficiary population. The National Institute on Aging (NIA) at the National Institutes of Health completed a comprehensive review of over 140 published cognitive screening tools to determine the level of evidence to support an instrument or set of instruments that could be used by providers. The review included the critical components identified by CMS as well as other psychometric properties. On October 31, 2011, NIA presented its findings to a large group of researchers, providers, federal policy staff, and other stakeholders for evaluation. Based on the questions raised and input provided by this group, NIA is continuing to add to the information on each tool and will provide additional information as it becomes available.
|
|
Detection of viral particles using RNA-Seq
|
Research Initiative
|
CDC
|
NHLBI
|
NexGen sequencing for unknown microbial agents in encephalitides, a fever of unknown origin in Kenyan patients.
|
|
Determining Autism in Somali Immigrants in the Minneapolis Region
|
Research Initiative
|
CDC
|
NICHD, NIEHS, NIMH, NIMHD
|
Several ICs at NIH are providing funds to CDC to support surveillance of Autism Spectrum Disorder (ASD) in select children who live in Minneapolis, with the goal of determining whether children of Somali descent have a higher ASD prevalence.
|
|
Developing Clinical Vocabulary Standards for Public Health Reporting
|
Resource Development
|
CDC
|
NLM
|
This collaboration between NLM and CDC is to develop Logical Observation Identifiers Names and Codes (LOINC) for use public health reporting, including tumor registry reporting, and reportable disease reporting.
|
|
Development and Use of a Non-human Primate Model of Pertussis Diseases and Transmission
|
Research Initiative
|
FDA
|
NIAID
|
NIH has been working with the FDA for development and use of a non-human primate (NHP) model of pertussis diseases and transmission.
|
|
Development of Chemical Emergency Medical Management Website
|
Other
|
OS
|
NICHD, NEI, NIA, NIDA, NINDS
|
This websites development is under the auspices of the National Library of Medicine SIS Division. Additional funding is provided by the Biomedical Advanced Research and Development Authority (HHS). NICHD staff is detailed to assist the NLM in its development with primary responsibility for the creation of the medical management guidelines component.
|
|
Development of In-Vitro Assays to Assess the Potency of Botulinum Neurotoxin Type A
|
Research Initiative
|
FDA
|
NINDS, NIAID
|
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop new non-animal-based assays to assess the potency of botulinum neurotoxin type A (BoNT/A) in a Good Manufacturing Practice (GMP) commercial environment. (STTR [R41/R42]) [PA-09-178], (SBIR [R43/R44]) [PA-09-179].
|